Engineering strain for producing urolithin A and application thereof
By constructing a co-expression vector pET28a-UroA containing tannic acid hydrolase, esterase, gallic acid decarboxylase and dopamine dehydroxylase, the problems of complex production and unstable yield of urolithin A in the existing technology have been solved, realizing efficient and simple large-scale production of urolithin A, which is suitable for functional food raw materials.
Patent Information
- Application Number
- CN202512007244.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-29
- Publication Date
- 2026-04-07
AI Technical Summary
Existing chemical synthesis methods for preparing urolithin A are complex and unsuitable for food additives, while biosynthesis methods suffer from the influence of microbial flora on yield and the generation of various urolithins, resulting in a lack of efficient large-scale production methods.
A co-expression vector pET28a-UroA containing tannic acid hydrolase, esterase, gallic acid decarboxylase and dopamine dehydroxylase was constructed and transformed into Escherichia coli BL21 to achieve whole-cell catalysis of ellagitannin to urolithin A.
It enables efficient and simple large-scale production of urolithin A, avoiding complex extraction and purification processes, is environmentally friendly and low-cost, and is suitable for functional food ingredients.